The International Journal of Tuberculosis and Lung Disease
18 papers4 directions
The International Journal of Tuberculosis and Lung Disease (IJTLD) is a research venue focused on respiratory health, with a specific emphasis on tuberculosis, HIV co-infection, and chronic obstructive pulmonary disease. Active from 2011 through 2025, the journal publishes work concerning clinical management, public health policy, and epidemiological risk factors. Notable contributors to the venue include Amrita Daftary, Jennifer Zelnick, and K. Rivet Amico, among others.
In the context of machine learning and artificial intelligence, the journal serves as a platform for evaluating the implementation of digital health technologies in respiratory medicine. Research in this area includes the assessment of automated diagnostic tools, such as CAD4TB software, and the utilization of digitized programmatic data to improve tuberculosis research outcomes. These studies often address the technical requirements for software regulation and the practical application of triaging thresholds in clinical environments.
The venue also documents the intersection of biological research and social health determinants. Published papers cover diverse topics ranging from the relationship between Toll-like receptor 4 and type-2 diabetes to the impact of smoked drug use on bacterial burden in tuberculosis patients. By integrating clinical reports with data-driven analysis, the journal provides insights into the management of multidrug-resistant tuberculosis and the health experiences of specific populations globally.
Papers by Year
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2017 | 1 |
| 2016 | 3 |
| 2015 | 1 |
| 2014 | 2 |
| 2013 | 1 |
| 2012 | 2 |
| 2011 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
| Author | Papers |
|---|---|
| Christoph Lippert | 1 |